XPeng Has Too Many Risks And No Convincing Reasons To Invest Here

Summary:

  • The valuation is neither cheap nor expensive, but you could buy the highly profitable BYD at a similar price.
  • The development of revenue and margins is stagnating while operating in highly competitive markets.
  • The long list of risks shows the negative aspects that could lurk in the future.
  • Further share dilution is also likely.

XPeng Motors‘s sales store and service center at night

Robert Way

Investment Thesis

XPeng (NYSE:XPEV) continues to achieve rising car sales figures, but this has not led to significantly higher sales and better margins in the past two years. It is questionable whether this trend will continue, given the immense

Investor’s Checklist

Check

Description

Rising revenues?

No

Increasing over longer periods

Improving margins?

No

Possible competitive edge

PEG ratio below one?

No

PEG ratio below one may suggest undervaluation

Sufficient cash reserves?

No

Vital for the survival & growth, especially of unprofitable companies

Rewards shareholders?

No

Returning capital to shareholders

Shareholder negatives?

Yes

Actions that disadvantage shareholders

Stock in an uptrend?

No

Trading above its 200-day moving average?


Analyst’s Disclosure: I/we have a beneficial long position in the shares of BYDDF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *